| Wissenschaftl. Titel | Neoadjuvant, sequential chemotherapy with docetaxel followed by Fluorouracil, Epirubicin, and Cyclophosphamid every 3 weeks - genome wide expression analysis for identification of a predictive gene signature in patients with primary breast cancer |
| Erkrankung |
Gyn:
Mamma-Ca:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
erstellt 17.05.2016 Data entry V CCP
geändert 02.10.2020 Data entry XI CCP